New Hope Against a Rare but Incurable Eye Cancer

TUESDAY, April 20, 2021 — A cutting-edge experimental drug cuts nearly in half the risk of death among patients with a rare but aggressive cancer of the eye, new clinical trial data show.
Tebentafusp has now become the first drug shown to improve…
Source: Topamax